HK Stock MarketDetailed Quotes

KEYMED BIO-B (02162)

Watchlist
  • 80.300
  • 0.0000.00%
15min DelayNot Open Aug 24 16:08 CST
23.99BMarket Cap26.93P/E (TTM)

KEYMED BIO-B (02162) Cash Flow

Cumulative·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
Operating Cash Flow
+9.78%-712.41M
+50.55%-180.96M
-160.07%-789.63M
-1023.06%-365.92M
+24.46%-303.62M
+123.97%39.64M
-87.26%-401.93M
-95.14%-165.38M
-79.82%-214.64M
-6.18%-84.75M
-74.56%-119.36M
---79.82M
---68.38M
Operating Income before the Change of Operating Capital
+12.72%-571.39M
+64.01%-110.20M
-102.10%-654.64M
-1160.09%-306.17M
+18.26%-323.91M
+142.50%28.88M
-82.22%-396.26M
+46.68%-67.95M
-82.48%-217.47M
-266.17%-127.43M
-93.99%-119.17M
---34.80M
---61.43M
Profit before Tax
-2.37%-520.72M
+77.11%-75.66M
-42.80%-508.65M
-786.52%-330.52M
-17.32%-356.19M
+1807.49%48.15M
+92.20%-303.60M
+100.07%2.52M
-375.38%-3.89B
-10130.60%-3.63B
-388.83%-818.85M
---35.49M
---167.51M
Attributable Subsidiary (Profit) Loss
-87.18%674.00K
-66.67%566.00K
+10.70%5.26M
-19.03%1.70M
-51.11%4.75M
-76.20%2.10M
+1250.63%9.71M
--8.81M
--719.00K
----
----
----
----
Interest (Income) - Adjustment
+20.54%-70.19M
+4.21%-39.87M
+0.02%-88.33M
-10.82%-41.62M
-62.65%-88.35M
-117.53%-37.56M
-674.50%-54.32M
-823.81%-17.27M
-27.90%-7.01M
+18.67%-1.87M
-390.87%-5.48M
---2.30M
---1.12M
Depreciation and Amortization:
+5.15%98.03M
+5.50%48.89M
+34.80%93.23M
+72.86%46.34M
+91.46%69.16M
+79.88%26.81M
+71.86%36.12M
+42.17%14.90M
+10.67%21.02M
+23.75%10.48M
+54.42%18.99M
--8.47M
--12.30M
-Amortization of Intangible Assets
+73.85%2.41M
+381.05%1.19M
+259.59%1.39M
+28.50%248.00K
+14.88%386.00K
+28.67%193.00K
+336.36%336.00K
+650.00%150.00K
+305.26%77.00K
--20.00K
--19.00K
----
----
Impairment and Provisions:
-13.61%933.00K
---265.00K
--1.08M
----
----
----
----
----
----
----
----
----
----
-Impairment of Inventory (Reversal)
--1.21M
----
----
----
----
----
----
----
----
----
----
----
----
-Impairment of Trade Receivables (Reversal)
----
--615.00K
----
----
----
----
----
----
----
----
----
----
----
-Other Impairments and Provisions
-125.37%-274.00K
---880.00K
--1.08M
----
----
----
----
----
----
----
----
----
----
Revaluation Surplus:
-49683.87%-30.87M
+91.06%-230.00K
---62.00K
+43.13%-2.57M
----
---4.52M
----
----
+399.82%3.48B
+878535.66%3.40B
+618.96%696.31M
---387.00K
--96.85M
-Other Fair Value Changes
-49683.87%-30.87M
+91.06%-230.00K
---62.00K
+43.13%-2.57M
----
---4.52M
----
----
+399.82%3.48B
+878535.66%3.40B
+618.96%696.31M
---387.00K
--96.85M
Asset Sale Loss (Gain):
---31.00K
--0.00
----
----
-81.89%71.00K
-97.41%7.00K
-44.40%392.00K
--270.00K
--705.00K
----
----
----
----
-Loss (Gain) On Sale of Property, Machinery and Equipment
---43.00K
---12.00K
----
----
-81.89%71.00K
-97.41%7.00K
-44.40%392.00K
--270.00K
--705.00K
----
----
----
----
-Loss (Gain) from Selling Other Assets
--12.00K
--12.00K
----
----
----
----
----
----
----
----
----
----
----
Financial Expense
-8.41%16.91M
-15.80%7.46M
+6.96%18.46M
-5.07%8.86M
+105.54%17.26M
+601.43%9.34M
-24.58%8.40M
-77.97%1.33M
-22.20%11.13M
+130.83%6.04M
+152.05%14.31M
--2.62M
--5.68M
Exchange Loss (Gain)
+272.56%31.32M
+248.02%8.85M
-63.78%-18.15M
+80.79%-5.98M
+92.03%-11.08M
+68.79%-31.11M
-354.07%-139.03M
-915.09%-99.69M
+351.20%54.72M
-303.54%-9.82M
-1994.62%-21.78M
--4.83M
---1.04M
Special Items
+38.12%-97.45M
-439.88%-59.93M
-489.20%-157.48M
+12.44%17.63M
-12.15%40.46M
-25.93%15.68M
-59.45%46.06M
-78.53%21.17M
+4357.46%113.59M
+886.24%98.62M
+59.51%-2.67M
---12.54M
---6.59M
Change of Operating Capital
+12.09%-816.67M
+46.29%-233.51M
-243.82%-928.99M
-906.76%-434.76M
+34.35%-270.20M
+120.20%53.89M
-104.94%-411.58M
-137.56%-266.79M
-54.66%-200.83M
+11.49%-112.30M
-67.28%-129.85M
---126.88M
---77.62M
Accounts Receivable (Increase) Decrease
+17.44%-38.61M
-1329.67%-40.49M
-190.60%-46.76M
+158.58%3.29M
---16.09M
---5.62M
----
----
----
----
----
----
----
Inventory (Increase) Decrease
-55.74%-85.76M
-91.13%-52.71M
-364.36%-55.07M
+23.26%-27.58M
+57.80%-11.86M
-66.54%-35.94M
-194.35%-28.10M
-57.54%-21.58M
-169.69%-9.55M
-327.76%-13.70M
-9.43%-3.54M
---3.20M
---3.24M
Accounts Payable Increase (Decrease)
+230.99%45.68M
+129.21%18.70M
-132.19%-34.87M
-242.99%-64.00M
+107.51%108.34M
+233.30%44.76M
+40.48%52.21M
-229.56%-33.58M
+338.81%37.16M
+3111.15%25.91M
+22.40%8.47M
--807.00K
--6.92M
Prepayments (Increase) Decrease
-865.46%-25.58M
+12.89%21.95M
+94.36%-2.65M
+75.98%19.44M
-39.12%-46.96M
+123.89%11.05M
-144.47%-33.76M
-16.31%-46.26M
+10.43%-13.81M
+10.97%-39.77M
-19.24%-15.42M
---44.67M
---12.93M
Cash from Business Operations
+14.90%-675.65M
+56.60%-162.75M
-173.33%-793.99M
-969.50%-375.00M
+28.44%-290.49M
+125.47%43.13M
-99.31%-405.91M
-9.27%-169.36M
-57.07%-203.66M
-89.32%-154.99M
-83.45%-129.66M
---81.87M
---70.68M
Other Taxes
+80.20%-1.23M
-35.06%-1.23M
-369.37%-6.19M
---907.00K
---1.32M
----
----
----
----
----
----
----
----
Special items of business operations
-436.79%-35.53M
-270.03%-16.98M
+189.31%10.55M
+386.43%9.99M
-396.78%-11.81M
-187.59%-3.49M
+136.25%3.98M
-94.33%3.98M
-206.60%-10.98M
+3326.15%70.24M
+347.83%10.30M
--2.05M
--2.30M
Net cash flow from investing
-42.29%39.08M
-400.99%-199.69M
-85.54%67.71M
-108.97%-39.86M
+172.52%468.20M
+229.49%444.30M
+68.29%-645.59M
-738.70%-343.11M
-1700.60%-2.04B
+80.23%-40.91M
-94.88%-113.07M
---206.97M
---58.02M
Sale of Fixed Assets
--1.87M
--333.00K
----
----
----
----
----
----
----
----
----
----
----
Purchase of Fixed Assets
-60.61%-333.92M
-39.23%-149.57M
+36.46%-207.91M
+57.01%-107.43M
-17.35%-327.19M
-33.82%-249.88M
-62.31%-278.82M
-1150.98%-186.73M
-767.34%-171.79M
-69.59%-14.93M
+68.19%-19.81M
---8.80M
---62.26M
Purchase of Intangible Assets
+61.13%-2.56M
+99.28%-11.00K
+88.12%-6.58M
+96.91%-1.54M
-7512.09%-55.42M
-8229.26%-49.81M
+32.09%-728.00K
-208.25%-598.00K
-1091.11%-1.07M
-57.72%-194.00K
-136.84%-90.00K
---123.00K
---38.00K
Cash Received from Disposal of Investments
-36.66%108.20M
-46.25%21.50M
-48.52%170.83M
-63.41%40.00M
-26.30%331.86M
-68.89%109.32M
+220.33%450.27M
+1698.62%351.36M
-63.55%140.57M
-89.44%19.54M
+48.21%385.60M
--184.91M
--260.17M
Cash Paid to Acquire Investments
-234725.00%-469.65M
---45.50M
+99.93%-200.00K
----
+56.55%-276.68M
+64.25%-146.23M
-245.24%-636.78M
-396.36%-409.00M
+44.02%-184.45M
+39.41%-82.40M
-28.21%-329.50M
---136.00M
---257.00M
Interest Received - Investment
+15.22%79.78M
+8.11%38.17M
-17.78%69.24M
-6.01%35.30M
+61.83%84.22M
+146.10%37.56M
+772.55%52.04M
+716.53%15.26M
+26.60%5.96M
+89.75%1.87M
+321.75%4.71M
--985.00K
--1.12M
Restricted Cash (Increase) Decrease
----
----
+200.00%1.78M
--1.78M
---1.78M
----
----
----
----
----
----
----
----
Loan Receivable (Increase) Decrease
---28.35M
-70.01%230.00K
----
-21.41%767.00K
+135.99%2.58M
--976.00K
--1.09M
----
----
----
----
----
----
Decrease in Deposits (Increase)
+7725.98%627.16M
-396.51%-122.84M
-101.27%-8.22M
-103.33%-24.74M
+266.09%645.29M
+485.28%742.37M
+78.50%-388.51M
-696.54%-192.68M
-1022.49%-1.81B
+113.03%32.30M
---160.98M
---247.94M
----
Other Items of Investing Activities
+15.90%56.54M
+262.50%58.00M
-25.33%48.79M
--16.00M
-58.08%65.34M
----
+961.34%155.85M
+2627.18%79.28M
-358.49%-18.09M
--2.91M
--7.00M
----
----
Financing Cash Flow
+177.82%788.72M
+235.51%885.50M
+293.59%283.90M
+6820.75%263.92M
+995.04%72.13M
-106.10%-3.93M
-100.22%-8.06M
-91.59%64.34M
+49087.18%3.64B
+6721.62%765.18M
-98.54%7.40M
--11.22M
--505.07M
New Borrowing
+39.53%654.09M
-8.28%386.29M
+30.22%468.79M
+63.88%421.18M
+300.22%360.00M
+133.64%257.00M
--89.95M
--110.00M
----
----
----
----
--239.00K
Refund
-431.48%-619.35M
-152.47%-268.58M
-59.92%-116.53M
-65.40%-106.38M
-22116.46%-72.87M
---64.32M
+99.22%-328.00K
----
-644.92%-41.82M
-654.91%-42.37M
---5.61M
---5.61M
----
Issuing Shares
--791.68M
--791.68M
----
----
----
----
----
----
+108094.30%3.76B
+24996.72%872.11M
-99.15%3.48M
--3.48M
--410.50M
Issuance Expenses and Redemption of Securities Expenses
+70.76%-9.48M
+70.76%-9.48M
+1.44%-32.43M
-12.77%-32.43M
+59.70%-32.90M
+25.52%-28.75M
-22.50%-81.65M
+37.36%-38.61M
---66.65M
---61.63M
----
----
----
Interest Paid - Financing
+12.92%-15.80M
+0.01%-8.08M
-73.02%-18.15M
-105.91%-8.08M
-465.95%-10.49M
---3.92M
---1.85M
----
----
----
----
----
----
Other Items of the Financing Business
-7.62%1.14M
----
+100.81%1.23M
----
-45355.03%-152.96M
---150.60M
+110.49%338.00K
----
-121.47%-3.22M
----
-85.00%15.00M
--15.00M
--100.00M
Effects of Exchange Rate Changes
-662.75%-30.46M
+2392.70%18.45M
-47.17%5.41M
-97.62%740.00K
-92.63%10.25M
-68.79%31.11M
+308.60%139.03M
+1973.56%99.69M
-715.99%-66.65M
-187.29%-5.32M
-258.85%-8.17M
--6.10M
--5.14M
Ending Cash Balance
+20.30%503.35M
+32.65%941.71M
-50.83%418.41M
-36.34%709.91M
+40.88%851.03M
-5.18%1.12B
-60.27%604.07M
+41.09%1.18B
+662.56%1.52B
+410.98%833.61M
-53.91%199.41M
--163.14M
--432.61M
Net Change in Cash
+126.34%115.39M
+455.89%504.86M
-285.05%-438.03M
-129.55%-141.86M
+122.43%236.71M
+208.07%480.02M
-176.06%-1.06B
-169.45%-444.15M
+716.74%1.39B
+332.08%639.52M
-159.43%-225.03M
---275.57M
--378.67M
Beginning Cash Balance
-50.83%418.41M
-50.83%418.41M
+40.88%851.03M
+40.88%851.03M
-60.27%604.07M
-60.27%604.07M
+662.56%1.52B
+662.56%1.52B
-53.91%199.41M
-53.91%199.41M
+786.51%432.61M
--432.61M
--48.80M
Deadline
Dec 31, 2025
Jun 30, 2025
Dec 31, 2024
Jun 30, 2024
Dec 31, 2023
Jun 30, 2023
Dec 31, 2022
Jun 30, 2022
Dec 31, 2021
Jun 30, 2021
Dec 31, 2020
Jun 30, 2020
Dec 31, 2019
Accounting Standard
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
2025/FY2025/H12024/FY2024/H12023/FY2023/H12022/FY2022/H12021/FY2021/H12020/FY2020/H12019/FY

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More